Vijay Siegfried

Bachelor of Medicine and Bachelor of Science,  Toronto General - University Health Network 

Location: Germany

Consulting Services

Research Consulting Grant Submission Admin and Customer Support

Areas Of Interest

Analyses, Psychodynamic Youths, Street dextro-Amphetamine Drug Evaluation, FDA Phase 3 as Topic Amuno Mustard, Sulfur Shigella Vaccines Brucelloses, Bovine Glycoprotein Sialyltransferase Pet Therapies Cyathus Memory Losses, Retrograde Cytidine Cyclic 3,5 Monophosphate Vitrification Qinghao Code, Ethical Calculus, Renal Record, Death Self-Evaluations SGLT 2 Inhibitors Desmethyl Sildenafil Human Babesioses Acids, Nipecotic Receptors, 1,25-Dihydroxyvitamin D3 Ultrasonic Vibrations

Professional Narrative

Dr. Vijay Siegfried was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Siegfried has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Assistant Professor, Harvard Med 2004
Senior Director, Harvard Med 1996

Education

Doctor of osteopathic medicine, Harvard Medical School 2013
Doctor of osteopathic medicine, Weill Medical College 2014

Referees


Publications

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :